C. Bjartmar

发表

Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences

B. Trapp, C. Bjartmar, 2001, Current opinion in neurology.

Axonal loss in normal-appearing white matter in a patient with acute MS

R. Kinkel, R. Rudick, B. Trapp, 2001, Neurology.

Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson’s Disease Rating Scale

C. Bjartmar, J. Bring, A. Członkowska, 2018, BMC Neurology.

Molecular heterogeneity of oligodendrocytes in chicken white matter

C. Bjartmar, C. Hildebrand, E. S. Anderson, 1999, Glia.

Morphological heterogeneity of rat oligodendrocytes: Oligodendrocytes: Electron microscopic studies on serial sections

C. Bjartmar, C. Hildebrand, K. Loinder, 1994 .

Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients

R. Rudick, B. Trapp, S. Mörk, 2000, Annals of neurology.

Myelinated nerve fibres in the CNS

H. Persson, C. Bjartmar, C. Hildebrand, 1993, Progress in Neurobiology.

Axonal pathology in myelin disorders

Bruce D. Trapp, B. Trapp, C. Bjartmar, 1999, Journal of neurocytology.

N‐acetylaspartate is an axon‐specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve

B. Trapp, C. Bjartmar, E. Dupree, 2002, Annals of neurology.

Oligodendroglial sheath lengths in developing rat ventral funiculus and corpus callosum

C. Bjartmar, 1996, Neuroscience Letters.

Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.

A. Pestronk, C. Bjartmar, R. Carlier, 2016, Molecular genetics and metabolism.

βIV tubulin is selectively expressed by oligodendrocytes in the central nervous system

B. Trapp, C. Bjartmar, G. Kidd, 2005 .

Beta IV tubulin is selectively expressed by oligodendrocytes in the central nervous system.

B. Trapp, C. Bjartmar, G. Kidd, 2005, Glia.

The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to β1 integrin, CD81, and Tspan‐2

B. Trapp, P. Brophy, C. Bjartmar, 2002, Glia.

Sheath lengths of large motor axons in the ventral root L5 of neonatal and adult rats

C. Bjartmar, C. Hildebrand, S. Loeliger, 1996, Neuroscience Letters.

Developing chicken oligodendrocytes express the type IV oligodendrocyte marker T4-O in situ, but not in vitro

C. Bjartmar, C. Hildebrand, E. S. Anderson, 2000, Neuroscience Letters.

Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis

B. Trapp, R. Ransohoff, C. Bjartmar, 2002, Journal of neuropathology and experimental neurology.

Axonal degeneration and progressive neurologic disability in multiple sclerosis

Bruce D. Trapp, B. Trapp, C. Bjartmar, 2009, Neurotoxicity Research.

Morphological heterogeneity of rat oligodendrocytes: electron microscopic studies on serial sections.

C. Bjartmar, C. Hildebrand, K. Loinder, 1994, Glia.

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.

J. Bronstein, C. Bjartmar, F. Askari, 2017, The lancet. Gastroenterology & hepatology.

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

B. Trapp, C. Bjartmar, C Bjartmar, 2003, Journal of the Neurological Sciences.

Morphological heterogeneity of cultured spinal and cerebral rat oligodendrocytes

C. Bjartmar, 1998, Neuroscience Letters.

Cellular and extracellular components at nodes of Ranvier in rat white matter

C. Bjartmar, C. Hildebrand, B. Karlsson, 1994, Brain Research.

Neuropathology and Disease Progression in Multiple Sclerosis

B. Trapp, C. Bjartmar, 2004 .

Axonal Loss in Multiple Sclerosis

B. Trapp, C. Bjartmar, 2001 .

A real-time insight into disease progression and the role of axonal injury in multiple sclerosis.

R. Ransohoff, C. Bjartmar, G. Kidd, 2001, Archives of neurology.

Postmortem Degradation of N-Acetyl Aspartate and N-Acetyl Aspartylglutamate: An HPLC Analysis of Different Rat CNS Regions

B. Trapp, C. Bjartmar, Jan Battistuta, 2001, Neurochemical Research.

Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease

J. Clancy, J. Charrow, C. Tifft, 2015, Neuromuscular Disorders.

Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.

A. Pestronk, C. Bjartmar, R. Carlier, 2016, Molecular genetics and metabolism.

Myelination of prospective large fibres in chicken ventral funiculus

C. Bjartmar, C. Hildebrand, E. S. Anderson, 2000, Journal of neurocytology.

[Oligodendrocytes have a key role in the development of CNS function and in myelin related diseases].

C. Bjartmar, E. S. Anderson, 2000, Lakartidningen.